According to Evolent Health's latest financial reports the company's current earnings (TTM) are -$0.14 B. In 2022 the company made an earning of -$46.51 M a decrease over its 2021 earnings that were of -$4.38 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.14 B | 197.92% |
2022 | -$46.51 M | 962.73% |
2021 | -$4.38 M | -98.58% |
2020 | -$0.31 B | -1.32% |
2019 | -$0.32 B | 542.29% |
2018 | -$48.67 M | -33.12% |
2017 | -$72.77 M | -7.9% |
2016 | -$79.01 M | 26.77% |
2015 | -$62.32 M | 435.21% |
2014 | -$11.65 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() National Healthcare
NHC | $41.65 M | -130.06% | ๐บ๐ธ USA |
![]() Global Cord Blood CORBF | $94.91 M | -168.51% | ๐ญ๐ฐ Hong Kong |
![]() Graham Holdings GHC | $0.36 B | -366.20% | ๐บ๐ธ USA |
![]() CryoLife CRY | $2.06 M | -101.49% | ๐บ๐ธ USA |